Display options
Cite
Araujo A, Martin F. SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1. Sex Transm Infect. 2021;doi: 10.1136/sextrans-2021-055007.
Araujo, A., & Martin, F. (2021). SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1. Sexually transmitted infections, . https://doi.org/10.1136/sextrans-2021-055007
Araujo, Abelardo, and Martin, Fabiola. "SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1." Sexually transmitted infections vol. (2021). doi: https://doi.org/10.1136/sextrans-2021-055007
Araujo A, Martin F. SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1. Sex Transm Infect. 2021 May 26; doi: 10.1136/sextrans-2021-055007. Epub 2021 May 26. PMID: 34039746; PMCID: PMC8159662.
Copy Download .nbib Format: NLM
Share it on

Sex Transm Infect. 2021 May 26; doi: 10.1136/sextrans-2021-055007. Epub 2021 May 26.

SARS-CoV-2 vaccination of people living with human T leukaemia virus type 1.

Sexually transmitted infections

Abelardo Araujo, Fabiola Martin

Affiliations

  1. National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Rio de Janeiro, Brazil.
  2. School of Public Health, University of Queensland, Brisbane, Queensland, Australia [email protected].

PMID: 34039746 PMCID: PMC8159662 DOI: 10.1136/sextrans-2021-055007

[No abstract available.]

Keywords: ATL; COVID-19; HAM/TSP; HTLV; SARS; vaccine

Conflict of interest statement

Competing interests: None declared.

References

  1. Nature. 2020 Oct;586(7830):516-527 - PubMed

Publication Types